Taiko Pharmaceutical Co.,Ltd. provided earnings guidance for the year ending December 2024. For the year, the company expects net sales of ¥6,800 million, operating profit of ¥410 million, profit attributable to owners of parent of ¥350 million and basic earnings per share of ¥6.98.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
349 JPY | -0.57% | +5.12% | +15.18% |
1st Jan change | Capi. | |
---|---|---|
+15.18% | 112M | |
+19.27% | 43.18B | |
+22.12% | 23.23B | |
+15.11% | 14.6B | |
+38.36% | 11.5B | |
-7.91% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- 4574 Stock
- News Taiko Pharmaceutical Co.,Ltd.
- Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2024